Life Sciences & Healthcare
Rapid transformation in the Life Sciences and Healthcare industry can require businesses to strike a balance between patient demands, market potential and policy compliance, while continuing to innovate. We create solutions that can help you to remain competitive in this constantly evolving market.
For a more innovative, equitable and sustainable future
Innovation is blurring the traditional boundaries in the Life Sciences and Healthcare industry. Our extensive industry experience, differentiated market research, Data and insights give us a comprehensive understanding of the opportunities and challenges of the changing Healthcare ecosystem.
We are positioned to help you to drive your business forward—not only because we understand complex problems, but because we have the skills, tools and multi-disciplinary solutions to help solve them. Through deep understanding of our vision of the Future of Health, health equity and Digital Transformation, we can help you navigate the industry’s transformation as exponential innovation propels Healthcare to the future.
Our Thinking
Empowering the Health Care workforce for a climate-resilient future
In this report, Project HOPE and Deloitte US have brought together frontline Healthcare workers, programme leaders, health system advisors, policy and advocacy professionals, community leaders and strategic relationships to collaborate on potential solutions for enhancing climate resilience.
Platform business models: Private Equity opportunities in the Life Sciences and Healthcare sector
Platform businesses are rewiring the traditional value chain. In nearly every industry, well-thought-out platform businesses typically beat traditional businesses because of superior unit economics and network effects.
Electronic Health Records Solution
Deloitte's Electronic Health Record (EHR) solution helps health systems execute Digital Transformation that shifts legacy models into modern best practices anchored on elevating the human experience.
A path toward health equity
The COVID-19 pandemic exposed a glaring disparity in global vaccine access. The World Economic Forum (WEF) and Deloitte have been collaborating to tackle this challenge by advocating for regionalised vaccine manufacturing ecosystems. This approach aims to revolutionise vaccine production and distribution, promoting equity and resilience in the face of future health crises.
Explore the Life Sciences & Healthcare industry
Justin Scanlan
Vicky Levy
Todd Konersmann
